Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00131287

The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

Diabetes Mellitus, Type II Clinical Trial

Clinical Trial Summary

The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.

Clinical Trial Description

The researchers have the animal model that the extract of the Agaricus blazei Murill mushroom is effective in the treatment of type II DM mice conducted on 2002. The dose effects were also found. The researchers conducted the pilot study also showing the same effects in 2003. So the researchers designed this trial. The elixir of the Agaricus blazei Murill mushroom is popular in Taiwan for chronic diseases, such as type II DM. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00131287
Study type Interventional
Source ECbiotech Taiwan
Contact
Status Completed
Phase Phase 3
Start date July 2005
Completion date December 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT03596177 - A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus Phase 2
Completed NCT01728740 - Bioequivalence Study for Acarbose / Metformin FDC Phase 1
Completed NCT02648854 - Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers Phase 1
Recruiting NCT02347020 - Impact of Sleep and Meal Timing on Food Intake Regulation N/A
Completed NCT00577590 - Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM N/A
Completed NCT00094796 - Rosiglitazone to Reverse Metabolic Defects in Diabetes Phase 2
Completed NCT04830969 - Impact of Periodontal Therapy on Patients With Diabetes Phase 2
Completed NCT03112382 - Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus Phase 4
Recruiting NCT01197092 - The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II Phase 2
Completed NCT00649909 - Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients N/A
Terminated NCT00554697 - Diabetes Mellitus Type II and Tissue Oxygenation N/A
Not yet recruiting NCT05957224 - Differences in Postprandial Glucose Changes N/A
Active, not recruiting NCT02088658 - Technology Intensified Diabetes Education Study in African Americans N/A
Completed NCT00081328 - Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Phase 3
Completed NCT00482079 - A Study of MK0431 in Patients With Type 2 Diabetes (0431-010) Phase 2
Recruiting NCT04092738 - ´Sit Less, Move More` at Work: mHealth Intervention on Office Employees With Diabetes Type 2. N/A
Completed NCT03012074 - Episodic to Real-Time Care in Diabetes Self-Management N/A
Completed NCT02175537 - Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar N/A
Completed NCT01651065 - Micro-Clinic Obesity and Metabolic Risk Prevention Program N/A
Completed NCT00528918 - Comparison of Apidra to Regular Insulin in Hospitalized Patients N/A